by H Bonilla · 2023 · Cited by 63 — This model could represent a model of immune dysregulation due to SARS-CoV-2 infection and may allow testing of behavioral and pharmacologic interventions.
People also ask
What antibiotics are used for long COVID treatment?
by MJ Peluso · 2024 · Cited by 21 — In doing so, our goal is to explain how SARS-CoV-2 infection can cause long COVID and to identify potential therapeutic targets for each ...
by KH Dinnon III · 2022 · Cited by 18 — New antivirals, antibody therapies, vaccinations, and improved critical care strategies have diminished acute fatality rates (3). However, ~40% of symptomatic ...
by HE Davis · 2023 · Cited by 3034 — Long COVID is an often debilitating illness that occurs in at least 10% of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections.
by M Brambilla · 2025 · Cited by 1 — Low-grade inflammation, sustained mainly by CRP but also by IL-6, is present in long COVID patients and correlates with the degree of platelet activation.
by RD Holms · 2022 · Cited by 37 — Ezrin peptides are inhibitors of IL-1, IL-6, IL-8 and TNFa expression, so are now being investigated as potential therapy for long COVID/PASC.
by MJ Peluso · 2024 · Cited by 31 — In doing so, our goal is to explain how SARS-CoV-2 infection can cause long COVID and to identify potential therapeutic targets for each mechanism. Figure 3 ...
by AD Proal · 2021 · Cited by 825 — The individualized nature of PASC symptoms suggests that different therapeutic approaches may be required to best manage care for specific patients with the ...
by DO Griffin · 2024 · Cited by 4 — Here, we share the evidence regarding the abnormalities associated with postacute sequelae of COVID-19 (PASC) and therapeutics.
